Skip to main content
Clinical Trials/CTRI/2014/08/004842
CTRI/2014/08/004842
Completed
Phase 4

Evaluation of systemic and vascular inflammation by [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in patients with moderate to severe psoriasis randomized to different drug regimens

PGIMER0 sites16 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with moderate to severe psoriasis
Sponsor
PGIMER
Enrollment
16
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
PGIMER

Eligibility Criteria

Inclusion Criteria

  • Patients on topical or active light therapy

Exclusion Criteria

  • Patients with chronic inflammatory disease like diabetes mellitus, uncontrolled hypertension with SBP 180 mmHg and DBP 95 mmHg, cardiovascular disease and with coagulopathy
  • 2\.Patients on any systemic therapy for psoriasis like methotrexate, retinoids or biologics in preceding 6 weeks
  • 3\.Patients on tobacco, alcohol use that is 2 drinks per day or intravenous drug use.
  • 4\.Participated in a research study in preceding 6 weeks
  • 5\.Major surgery within 3 months of imaging
  • 6\.Pregnant females
  • 7\.Lactating mothers
  • 8\.Patient with liver disease
  • 9\.Blood glucose level 150 mg/dl
  • 10\.Any other inflammatory condition in the body that in the opinion of investigator may jeopardise the validity of the study or put the patients at the greater risk

Outcomes

Primary Outcomes

Not specified

Similar Trials